3-(2,1,3-benzoxadiazol-5-yl)-8-(dimethylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-4-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-methylpyrazin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[2-[8-(dimethylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]phenoxy]acetamide;8-(dimethylamino)-8-phenyl-3-pyrazin-2-yl-1,3-diazaspiro[4.5]decan-2-one

C127H155F2N29O9 — CID 158943290

IUPAC3-(2,1,3-benzoxadiazol-5-yl)-8-(dimethylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-4-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-methylpyrazin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[2-[8-(dimethylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]phenoxy]acetamide;8-(dimethylamino)-8-phenyl-3-pyrazin-2-yl-1,3-diazaspiro[4.5]decan-2-one
SMILESCN(C)C1(c2ccccc2)CCC2(CC1)CN(c1ccc3nonc3c1)C(=O)N2.CN(C)C1(c2ccccc2)CCC2(CC1)CN(c1ccccc1OCC(N)=O)C(=O)N2.CN(C)C1(c2ccccc2)CCC2(CC1)CN(c1cnccn1)C(=O)N2.CN(C)C1(c2ccccc2)CCC2(CC1)CN(c1ncc(F)cn1)C(=O)N2.CN(C)C1(c2ccccc2)CCC2(CC1)CN(c1ncncc1F)C(=O)N2.Cc1cnc(N2CC3(CCC(c4ccccc4)(N(C)C)CC3)NC2=O)cn1
InChIInChI=1S/C24H30N4O3.C22H25N5O2.C21H27N5O.2C20H24FN5O.C20H25N5O/c1-27(2)24(18-8-4-3-5-9-18)14-12-23(13-15-24)17-28(22(30)26-23)19-10-6-7-11-20(19)31-16-21(25)29;1-26(2)22(16-6-4-3-5-7-16)12-10-21(11-13-22)15-27(20(28)23-21)17-8-9-18-19(14-17)25-29-24-18;1-16-13-23-18(14-22-16)26-15-20(24-19(26)27)9-11-21(12-10-20,25(2)3)17-7-5-4-6-8-17;1-25(2)20(15-6-4-3-5-7-15)10-8-19(9-11-20)13-26(18(27)24-19)17-16(21)12-22-14-23-17;1-25(2)20(15-6-4-3-5-7-15)10-8-19(9-11-20)14-26(18(27)24-19)17-22-12-16(21)13-23-17;1-24(2)20(16-6-4-3-5-7-16)10-8-19(9-11-20)15-25(18(26)23-19)17-14-21-12-13-22-17/h3-11H,12-17H2,1-2H3,(H2,25,29)(H,26,30);3-9,14H,10-13,15H2,1-2H3,(H,23,28);4-8,13-14H,9-12,15H2,1-3H3,(H,24,27);3-7,12,14H,8-11,13H2,1-2H3,(H,24,27);3-7,12-13H,8-11,14H2,1-2H3,(H,24,27);3-7,12-14H,8-11,15H2,1-2H3,(H,23,26)
InChIKeyJKNANOJFDRQVQE-UHFFFAOYSA-N
MW2269.83 g/mol
LogP18.06
Rot. Bonds21

About 3-(2,1,3-benzoxadiazol-5-yl)-8-(dimethylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-4-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-methylpyrazin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[2-[8-(dimethylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]phenoxy]acetamide;8-(dimethylamino)-8-phenyl-3-pyrazin-2-yl-1,3-diazaspiro[4.5]decan-2-one

3-(2,1,3-benzoxadiazol-5-yl)-8-(dimethylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-4-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-methylpyrazin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[2-[8-(dimethylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]phenoxy]acetamide;8-(dimethylamino)-8-phenyl-3-pyrazin-2-yl-1,3-diazaspiro[4.5]decan-2-one (PubChem CID 158943290) has the molecular formula C127H155F2N29O9 and a molecular weight of 2269.83 g/mol. Its IUPAC name is 3-(2,1,3-benzoxadiazol-5-yl)-8-(dimethylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-4-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-methylpyrazin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[2-[8-(dimethylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]phenoxy]acetamide;8-(dimethylamino)-8-phenyl-3-pyrazin-2-yl-1,3-diazaspiro[4.5]decan-2-one.

Molecular Properties

Compound Name3-(2,1,3-benzoxadiazol-5-yl)-8-(dimethylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-4-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-methylpyrazin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[2-[8-(dimethylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]phenoxy]acetamide;8-(dimethylamino)-8-phenyl-3-pyrazin-2-yl-1,3-diazaspiro[4.5]decan-2-one
PubChem CID158943290
Molecular FormulaC127H155F2N29O9
Molecular Weight2269.83 g/mol
Exact Mass2268.25
IUPAC Name3-(2,1,3-benzoxadiazol-5-yl)-8-(dimethylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-4-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-methylpyrazin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[2-[8-(dimethylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]phenoxy]acetamide;8-(dimethylamino)-8-phenyl-3-pyrazin-2-yl-1,3-diazaspiro[4.5]decan-2-one
SMILESCN(C)C1(c2ccccc2)CCC2(CC1)CN(c1ccc3nonc3c1)C(=O)N2.CN(C)C1(c2ccccc2)CCC2(CC1)CN(c1ccccc1OCC(N)=O)C(=O)N2.CN(C)C1(c2ccccc2)CCC2(CC1)CN(c1cnccn1)C(=O)N2.CN(C)C1(c2ccccc2)CCC2(CC1)CN(c1ncc(F)cn1)C(=O)N2.CN(C)C1(c2ccccc2)CCC2(CC1)CN(c1ncncc1F)C(=O)N2.Cc1cnc(N2CC3(CCC(c4ccccc4)(N(C)C)CC3)NC2=O)cn1
InChIInChI=1S/C24H30N4O3.C22H25N5O2.C21H27N5O.2C20H24FN5O.C20H25N5O/c1-27(2)24(18-8-4-3-5-9-18)14-12-23(13-15-24)17-28(22(30)26-23)19-10-6-7-11-20(19)31-16-21(25)29;1-26(2)22(16-6-4-3-5-7-16)12-10-21(11-13-22)15-27(20(28)23-21)17-8-9-18-19(14-17)25-29-24-18;1-16-13-23-18(14-22-16)26-15-20(24-19(26)27)9-11-21(12-10-20,25(2)3)17-7-5-4-6-8-17;1-25(2)20(15-6-4-3-5-7-15)10-8-19(9-11-20)13-26(18(27)24-19)17-16(21)12-22-14-23-17;1-25(2)20(15-6-4-3-5-7-15)10-8-19(9-11-20)14-26(18(27)24-19)17-22-12-16(21)13-23-17;1-24(2)20(16-6-4-3-5-7-16)10-8-19(9-11-20)15-25(18(26)23-19)17-14-21-12-13-22-17/h3-11H,12-17H2,1-2H3,(H2,25,29)(H,26,30);3-9,14H,10-13,15H2,1-2H3,(H,23,28);4-8,13-14H,9-12,15H2,1-3H3,(H,24,27);3-7,12,14H,8-11,13H2,1-2H3,(H,24,27);3-7,12-13H,8-11,14H2,1-2H3,(H,24,27);3-7,12-14H,8-11,15H2,1-2H3,(H,23,26)
InChIKeyJKNANOJFDRQVQE-UHFFFAOYSA-N
XLogP18.06
TPSA407.84 Ų
H-Bond Donors7
H-Bond Acceptors25
Rotatable Bonds21
Heavy Atoms167
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002269.83
LogP ≤ 518.06
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1025

Analyze 3-(2,1,3-benzoxadiazol-5-yl)-8-(dimethylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-4-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-methylpyrazin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[2-[8-(dimethylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]phenoxy]acetamide;8-(dimethylamino)-8-phenyl-3-pyrazin-2-yl-1,3-diazaspiro[4.5]decan-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-(2,1,3-benzoxadiazol-5-yl)-8-(dimethylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-4-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-methylpyrazin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[2-[8-(dimethylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]phenoxy]acetamide;8-(dimethylamino)-8-phenyl-3-pyrazin-2-yl-1,3-diazaspiro[4.5]decan-2-one?
The IUPAC name of 3-(2,1,3-benzoxadiazol-5-yl)-8-(dimethylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-4-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-methylpyrazin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[2-[8-(dimethylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]phenoxy]acetamide;8-(dimethylamino)-8-phenyl-3-pyrazin-2-yl-1,3-diazaspiro[4.5]decan-2-one (CID 158943290) is 3-(2,1,3-benzoxadiazol-5-yl)-8-(dimethylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-4-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-methylpyrazin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[2-[8-(dimethylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]phenoxy]acetamide;8-(dimethylamino)-8-phenyl-3-pyrazin-2-yl-1,3-diazaspiro[4.5]decan-2-one.
What is the SMILES notation for 3-(2,1,3-benzoxadiazol-5-yl)-8-(dimethylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-4-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-methylpyrazin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[2-[8-(dimethylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]phenoxy]acetamide;8-(dimethylamino)-8-phenyl-3-pyrazin-2-yl-1,3-diazaspiro[4.5]decan-2-one?
The canonical SMILES for 3-(2,1,3-benzoxadiazol-5-yl)-8-(dimethylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-4-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-methylpyrazin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[2-[8-(dimethylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]phenoxy]acetamide;8-(dimethylamino)-8-phenyl-3-pyrazin-2-yl-1,3-diazaspiro[4.5]decan-2-one is CN(C)C1(c2ccccc2)CCC2(CC1)CN(c1ccc3nonc3c1)C(=O)N2.CN(C)C1(c2ccccc2)CCC2(CC1)CN(c1ccccc1OCC(N)=O)C(=O)N2.CN(C)C1(c2ccccc2)CCC2(CC1)CN(c1cnccn1)C(=O)N2.CN(C)C1(c2ccccc2)CCC2(CC1)CN(c1ncc(F)cn1)C(=O)N2.CN(C)C1(c2ccccc2)CCC2(CC1)CN(c1ncncc1F)C(=O)N2.Cc1cnc(N2CC3(CCC(c4ccccc4)(N(C)C)CC3)NC2=O)cn1.
What is the InChIKey of 3-(2,1,3-benzoxadiazol-5-yl)-8-(dimethylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-4-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-methylpyrazin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[2-[8-(dimethylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]phenoxy]acetamide;8-(dimethylamino)-8-phenyl-3-pyrazin-2-yl-1,3-diazaspiro[4.5]decan-2-one?
The InChIKey is JKNANOJFDRQVQE-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H30N4O3.C22H25N5O2.C21H27N5O.2C20H24FN5O.C20H25N5O/c1-27(2)24(18-8-4-3-5-9-18)14-12-23(13-15-24)17-28(22(30)26-23)19-10-6-7-11-20(19)31-16-21(25)29;1-26(2)22(16-6-4-3-5-7-16)12-10-21(11-13-22)15-27(20(28)23-21)17-8-9-18-19(14-17)25-29-24-18;1-16-13-23-18(14-22-16)26-15-20(24-19(26)27)9-11-21(12-10-20,25(2)3)17-7-5-4-6-8-17;1-25(2)20(15-6-4-3-5-7-15)10-8-19(9-11-20)13-26(18(27)24-19)17-16(21)12-22-14-23-17;1-25(2)20(15-6-4-3-5-7-15)10-8-19(9-11-20)14-26(18(27)24-19)17-22-12-16(21)13-23-17;1-24(2)20(16-6-4-3-5-7-16)10-8-19(9-11-20)15-25(18(26)23-19)17-14-21-12-13-22-17/h3-11H,12-17H2,1-2H3,(H2,25,29)(H,26,30);3-9,14H,10-13,15H2,1-2H3,(H,23,28);4-8,13-14H,9-12,15H2,1-3H3,(H,24,27);3-7,12,14H,8-11,13H2,1-2H3,(H,24,27);3-7,12-13H,8-11,14H2,1-2H3,(H,24,27);3-7,12-14H,8-11,15H2,1-2H3,(H,23,26).
What are the key properties of 3-(2,1,3-benzoxadiazol-5-yl)-8-(dimethylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-4-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-methylpyrazin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[2-[8-(dimethylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]phenoxy]acetamide;8-(dimethylamino)-8-phenyl-3-pyrazin-2-yl-1,3-diazaspiro[4.5]decan-2-one?
3-(2,1,3-benzoxadiazol-5-yl)-8-(dimethylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-4-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-methylpyrazin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[2-[8-(dimethylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]phenoxy]acetamide;8-(dimethylamino)-8-phenyl-3-pyrazin-2-yl-1,3-diazaspiro[4.5]decan-2-one has a molecular weight of 2269.83 g/mol, XLogP of 18.06, 21 rotatable bonds, 7 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(2,1,3-benzoxadiazol-5-yl)-8-(dimethylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-fluoropyrimidin-4-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-methylpyrazin-2-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[2-[8-(dimethylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]phenoxy]acetamide;8-(dimethylamino)-8-phenyl-3-pyrazin-2-yl-1,3-diazaspiro[4.5]decan-2-one is sourced from PubChem (CID 158943290), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).